Showing results (221-230 of 232) with videos related to

Sort By:
Pageof 24
Nature Communications|January 23, 2024
Durvalumab plus pazopanib combination in patients with advanced soft tissue sarcomas: a phase II trialHee Jin Cho, Kum-Hee Yun, Su-Jin Shin, et al.
Phytotherapy Research : PTR|November 15, 2025
Atranorin Impedes Glioma Invasiveness and Progression by Inhibiting the Epithelial-Mesenchymal Transition and Stemness in Monotherapy and in Combination Therapy With TemozolomideRui Zhou, Eun-Jung Ahn, Suresh R Bhosle, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2022
Phase II Clinical Trial of Eribulin-Gemcitabine Combination Therapy in Previously Treated Patients With Advanced Liposarcoma or LeiomyosarcomaChang Gon Kim, Nam Suk Sim, Jeong Eun Kim, et al.
Biologicals : Journal of the International Association of Biological Standardization|March 7, 2012
Immunogenicity of recombinant human erythropoietin in Korea: a two-year cross-sectional studySug-Kyun Shin, Sung Jin Moon, Sung Kyu Ha, et al.
Scientific Reports|November 4, 2018
Potassium usnate, a water-soluble usnic acid salt, shows enhanced bioavailability and inhibits invasion and metastasis in colorectal cancerYi Yang, Woo Kyun Bae, Ji-Yoon Lee, et al.
Oncology|October 19, 2018
Differences in the Efficacies of Pazopanib and Gemcitabine/Docetaxel as Second-Line Treatments for Metastatic Soft Tissue SarcomaJee Hung Kim, Hyung Soon Park, Su Jin Heo, et al.
Bioengineering & Translational Medicine|November 29, 2023
Enhancement of the therapeutic efficacy of the MAP regimen using thiamine pyrophosphate-decorated albumin nanoclusters in osteosarcoma treatmentSo-Yeol Yoo, Yong-Hyeon Mun, Nae-Won Kang, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|September 18, 2024
Laser-responsive erastin-loaded chondroitin sulfate nanomedicine targeting CD44 and system xc- in liver cancer: A non-ferroptotic approachSo-Yeol Yoo, Hyun Young Kim, Dong Hyun Kim, et al.
The Journal of Clinical Investigation|September 13, 2016
Interruption of progerin-lamin A/C binding ameliorates Hutchinson-Gilford progeria syndrome phenotypeSu-Jin Lee, Youn-Sang Jung, Min-Ho Yoon, et al.
Cell Metabolism|September 3, 2019
Glutamate Signaling in Hepatic Stellate Cells Drives Alcoholic SteatosisWon-Mook Choi, Hee-Hoon Kim, Myung-Ho Kim, et al.
Pageof 24